Cargando…

Impact of revised breakpoints on the categorization of susceptibility of Enterobacterales to temocillin

BACKGROUND: To harmonize with the EUCAST breakpoints, the French Society of Microbiology introduced a change in the inhibition diameter breakpoint (17 mm versus 20 mm previously) of temocillin. We assessed the impact of the new breakpoints on categorizing susceptibility of Enterobacterales to temoci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farfour, Eric, Le Brun, Cécile, Degand, Nicolas, Riverain, Emeline, Dinh, Aurélien, Timores, Thierry, Mamona, Christel, Vallée, Alexandre, Vasse, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627527/ https://www.ncbi.nlm.nih.gov/pubmed/37937260 http://dx.doi.org/10.1093/jacamr/dlad114

Ejemplares similares

Rapid detection of temocillin resistance in Enterobacterales
por: Findlay, Jacqueline, et al.
Publicado: (2023)

In vitro activity of mecillinam, temocillin and nitroxoline against MDR Enterobacterales
por: Plambeck, Lars, et al.
Publicado: (2022)

Activity of temocillin against ESBL-, AmpC-, and/or KPC-producing Enterobacterales isolated in Poland
por: Kuch, Alicja, et al.
Publicado: (2020)

Clinical outcomes of temocillin use for invasive Enterobacterales infections: a single-centre retrospective analysis
por: Heard, Katie L, et al.
Publicado: (2021)

Clinical and microbiological evaluation of temocillin for bloodstream infections with Enterobacterales: a Belgian single-centre retrospective study
por: Oosterbos, Julie, et al.
Publicado: (2022)

Real-life temocillin use in Greater Paris area, effectiveness and risk factors for failure in infections caused by ESBL-producing Enterobacterales: a multicentre retrospective study
por: Dinh, Aurélien, et al.
Publicado: (2022)

183. Impact of Revised Piperacillin/Tazobactam Clinical Breakpoints on Enterobacterales Isolates Identified in Blood Cultures
por: Moore, Nicholas M, et al.
Publicado: (2022)

Antimicrobial Resistance in Enterobacterales Recovered from Urinary Tract Infections in France
por: Farfour, Eric, et al.
Publicado: (2022)

Carbapenemase-producing Enterobacterales outbreak: Another dark side of COVID-19
por: Farfour, Eric, et al.
Publicado: (2020)

1278. Impact of Different Breakpoint Criteria on the Susceptibility Rates of Enterobacterales resistant Subsets to the Aminoglycosides
por: Sader, Helio S, et al.
Publicado: (2020)

Temocillin versus meropenem for the targeted treatment of bacteraemia due to third-generation cephalosporin-resistant Enterobacterales (ASTARTÉ): protocol for a randomised, pragmatic trial
por: Marín-Candón, Alicia, et al.
Publicado: (2021)

Inquilinus limosus Bacteremia in Lung Transplant Recipient after SARS-CoV-2 Infection
por: Farfour, Eric, et al.
Publicado: (2023)

Rarely Encountered Gram-Negative Rods and Lung Transplant Recipients: A Narrative Review
por: Farfour, Eric, et al.
Publicado: (2023)

Correction to: Real-life temocillin use in Greater Paris area, effectiveness and risk factors for failure in infections caused by ESBL-producing Enterobacterales: a multicentre retrospective study
Publicado: (2023)

Continuous versus intermittent infusion of temocillin in intensive care unit patients
por: Claeysoone, K, et al.
Publicado: (2005)

Temocillin: Applications in Antimicrobial Stewardship as a Potential Carbapenem-Sparing Antibiotic
por: Lupia, Tommaso, et al.
Publicado: (2022)

Susceptibility of Escherichia coli from Community-Acquired Urinary Tract Infection to Fosfomycin, Nitrofurantoin, and Temocillin in Korea
por: Seo, Mi-Ran, et al.
Publicado: (2014)

Clinical Impact of Revised Cefepime Breakpoint in Patients With Enterobacteriaceae Bacteremia
por: Foong, Kap Sum, et al.
Publicado: (2019)

Clinical Efficacy of Temocillin Standard Dosing in Patients Treated with Outpatient Antimicrobial Therapy
por: Van den Broucke, Evelyne, et al.
Publicado: (2022)

Empirical use of temocillin in hospitalized patients: results from a retrospective audit
por: Kandil, Hala, et al.
Publicado: (2023)

Categorization of radioactive sources. Revision of IAEA-TECDOC-1191, Categorization of radiation sources
Publicado: (2003)

The ID NOW COVID-19, a high-speed high-performance assay
por: Farfour, Eric, et al.
Publicado: (2021)

Correction to: Empirical use of temocillin in hospitalized patients: results from a retrospective audit
Publicado: (2023)

2801. Antimicrobial Spectrum of Plazomicin and Other Aminoglycosides against Multidrug-Resistant and Carbapenem-Resistant Enterobacterales When Applying New Breakpoints
por: Sader, Helio S, et al.
Publicado: (2023)

Usefulness of EUCAST rapid antibiotic susceptibility breakpoints and screening cut-off values directly from blood cultures for the inference of β-lactam resistance mechanisms in Enterobacterales
por: Cerrudo, V, et al.
Publicado: (2023)

SARS-CoV-2 RT-PCR and Chest CT, two complementary approaches for COVID-19 diagnosis
por: Farfour, Eric, et al.
Publicado: (2020)

Evaluation of Four Fully Integrated Molecular Assays for the Detection of Respiratory Viruses during the Co-Circulation of SARS-CoV-2, Influenza and RSV
por: Farfour, Eric, et al.
Publicado: (2022)

Clinical Impact of Revised Ciprofloxacin Breakpoint in Patients with Urinary Tract Infections by Enterobacteriaceae
por: Park, Ga Eun, et al.
Publicado: (2021)

Activity of temocillin and 15 other agents, including fosfomycin and colistin, against Enterobacteriaceae in Hong Kong
por: Ip, Margaret, et al.
Publicado: (2017)

Cost-Effectiveness Analysis of Temocillin Treatment in Patients with Febrile UTI Accounting for the Emergence of Antibiotic Resistance
por: Larsson, Sofie, et al.
Publicado: (2022)

Mechanisms of intrinsic resistance and acquired susceptibility of Pseudomonas aeruginosa isolated from cystic fibrosis patients to temocillin, a revived antibiotic
por: Chalhoub, Hussein, et al.
Publicado: (2017)

Comparative in vitro activity of piperacillin-tazobactam and temocillin against third-generation cephalosporin-resistant, carbapenem-susceptible Escherichia coli and Klebsiella pneumoniae
por: Kresken, Michael, et al.
Publicado: (2021)

Impact of the revised penicillin susceptibility breakpoints for Streptococcus pneumoniae on antimicrobial resistance rates of meningeal and non-meningeal pneumococcal strains
por: Al-Waili, Badria R., et al.
Publicado: (2013)

Activity of mecillinam against carbapenem-resistant Enterobacterales
por: Emeraud, Cécile, et al.
Publicado: (2022)

Budget impact analysis of temocillin insurance coverage for urinary tract infections caused by ESBL-producing pathogens in Iran
por: Seyedifar, Meysam, et al.
Publicado: (2023)

2760. Fecal Microbiota Transplantation for Decolonization of Carbapenemase-Producing Enterobacterales
por: Davido, Benjamin, et al.
Publicado: (2023)

Diccionario de las exploraciones
por: Riverain, Jean, 1907-
Publicado: (1970)

Susceptibility breakpoint for Danofloxacin against swine Escherichia coli
por: Yang, Yuqi, et al.
Publicado: (2019)

Time for Precision: A World Without Susceptibility Breakpoints
por: Bader, Justin C, et al.
Publicado: (2018)

Validation of Bedaquiline Phenotypic Drug Susceptibility Testing Methods and Breakpoints: a Multilaboratory, Multicountry Study
por: Kaniga, Koné, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3m2bi6jo43isu8mjh4gjk54fa0